Alu Elements in ANRIL Non-Coding RNA at Chromosome 9p21 Modulate Atherogenic Cell Functions through Trans-Regulation of Gene Networks
Open accessThe DOI matches its Crossref record; 60 of the 62 references it cites were found in a registry or an index.
Abstract
The chromosome 9p21 (Chr9p21) locus of coronary artery disease has been identified in the first surge of genome-wide association and is the strongest genetic factor of atherosclerosis known today. Chr9p21 encodes the long non-coding RNA (ncRNA) antisense non-coding RNA in the INK4 locus (ANRIL). ANRIL expression is associated with the Chr9p21 genotype and correlated with atherosclerosis severity. Here, we report on the molecular mechanisms through which ANRIL regulates target-genes in trans, leading to increased cell proliferation, increased cell adhesion and decreased apoptosis, which are all essential mechanisms of atherogenesis. Importantly, trans-regulation was dependent on Alu motifs, which marked the promoters of ANRIL target genes and were mirrored in ANRIL RNA transcripts. ANRIL bound Polycomb group proteins that were highly enriched in the proximity of Alu motifs across the genome and were recruited to promoters of target genes upon ANRIL over-expression. The functional relevance of Alu motifs in ANRIL was confirmed by deletion and mutagenesis, reversing trans-regulation and atherogenic cell functions. ANRIL-regulated networks were confirmed in 2280 individuals with and without coronary artery disease and functionally validated in primary cells from patients carrying the Chr9p21 risk allele. Our study provides a molecular mechanism for pro-atherogenic effects of ANRIL at Chr9p21 and suggests a novel role for Alu elements in epigenetic gene regulation by long ncRNAs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![Figure 4 Identification of Alu motifs in promoters of ANRIL trans-regulated genes and ANRIL RNA and their spatial relation to PcG protein binding. (A) DNA motif in promoters (5 kb) of trans-regulated genes representing an Alu-DEIN repeat [33]. (B) Number of Alu motifs in promoters of trans- and not regulated transcripts (n per 5 kb). (C) ChIP-seq enrichment of SUZ12 and CBX7 binding distal to Alu motif, demonstrating a specific spatial relation of motif occurrence to PcG protein binding. RPM- reads per million mapped reads, CTR- random DNA control sequence. (D) Motif-associated SUZ12 signal peaks in an independent data set from BGO3 cells. The actual signal peak only becomes apparent, if a multiple matching policy is adopted. (E) Using a strict unique-matches only policy, a substantial signal reduction is seen downstream of the motif. Please note differences in y-axis scaling in (D, E). (F) Secondary RNA structure prediction for ANRIL2 using the Vienna RNA package [58]. Within the minimum free energy structure, the Alu-DEIN motif is located in a stem-loop structure (arrow). (G) RIP demonstrating ANRIL binding to histone H3 (H3) and trimethylated lysine 27 of histone 3 (H3K27me3) in ANRIL2 (blue) and ANRIL4 (red) cells. U1 was used as negative control. mIgG/rIgG- mouse/rabbit IgG control. Error bars indicate s.e.m.](https://figures.cochat.ai/paper-figures/3d38d7a9963e478499e2c0998ca5fa70/alu-elements-in-anril-non-coding-rna-at-chromosome-9p21-modulate-atherogenic-figure-4.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Chr9p21 encodes the long non-coding RNA(ncRNA) ANRIL, which has been demonstrated to regulate cell proliferation, adhesion and apoptosis,(43, 44) - central mechanisms of atherogenesis (13, 43) and endometriosis. (2, 3)”
From Endometriosis and Risk of Coronary Heart Disease (2016) · cites this paper as [43]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
R: A Language for Data Analysis and Graphics
Ihaka, R., & Gentleman, R. (1996) · Journal of Computational and Graphical Statistics · doi:10.1080/10618600.1996.10474713 · Cited by 11,220 · cited 2×
“Associations of haplotypes with expression profiles, and correlation with ANRIL (Ex1-5, Ex18-19) were calculated using robust linear regression models as described (please refer to Supplemental Materials in [6]) with the R software for statistical computing [54].”
MethodMEME SUITE: tools for motif discovery and searching
Bailey, T. L., Boden, M., Buske, F. A., Frith, M., Grant, C. E., Clementi, L., Ren, J., Li, W. W., & Noble, W. S. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp335 · Cited by 10,648 · cited 2×
“The MEME package [57] was used to search for differences in motifs abundance in promoters (5 kb) of differentially regulated genes.”
MethodAdjusting batch effects in microarray expression data using empirical Bayes methods
Johnson, W. E., Li, C., & Rabinovic, A. (2007) · Biostatistics · doi:10.1093/biostatistics/kxj037 · Cited by 8,658 · cited 1×
“Preprocessing of genome-wide expression data in PBMC of the Leipzig LIFE Heart Study comprised selection of expressed features, outlier detection, normalization, and batch correction as described [52,53].”
MethodLong non-coding RNAs: insights into functions
Mercer, T. R., Dinger, M. E., & Mattick, J. S. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2521 · Cited by 5,654 · cited 1×
“Here, it was predicted to form a stem-loop structure in ANRIL RNA (Figure 4F) suggesting RNA-chromatin interactions as a potential effector mechanism [16].”
BackgroundLong non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis
Gupta, R. A., Shah, N., Wang, K. C., Kim, J., Horlings, H. M., Wong, D. J., Tsai, M.-C., Hung, T., Argani, P., Rinn, J. L., et al. (2010) · Nature · doi:10.1038/nature08975 · Cited by 5,218 · cited 2×
“On the mechanistic level, it has been postulated that long ncRNA may serve as a scaffold, guiding effector-proteins to chromatin [24–26,37–39].”
BackgroundLusis, A. J. (2000) · Nature · doi:10.1038/35025203 · Cited by 4,839
Circular RNAs are abundant, conserved, and associated with ALU repeats
Jeck, W. R., Sorrentino, J. A., Wang, K., Slevin, M. K., Burd, C. E., Liu, J., Marzluff, W. F., & Sharpless, N. E. (2013) · RNA · doi:10.1261/rna.035667.112 · Cited by 4,388
Functional Demarcation of Active and Silent Chromatin Domains in Human HOX Loci by Noncoding RNAs
Rinn, J. L., Kertesz, M., Wang, J. K., Squazzo, S. L., Xu, X., Brugmann, S. A., Goodnough, L. H., Helms, J. A., Farnham, P. J., Segal, E., et al. (2007) · Cell · doi:10.1016/j.cell.2007.05.022 · Cited by 4,244 · cited 1×
“Among the best studied examples is the long ncRNA HOTAIR, which is transcribed from the HOXC cluster and was shown to repress genes in the HOXD cluster in trans [25,26].”
BackgroundThe Polycomb complex PRC2 and its mark in life
Margueron, R., & Reinberg, D. (2011) · Nature · doi:10.1038/nature09784 · Cited by 3,347 · cited 1×
“PRCs are multiprotein complexes, responsible for initiating and maintaining epigenetic chromatin modifications and thereby controlling gene expression [21].”
BackgroundLong Noncoding RNA as Modular Scaffold of Histone Modification Complexes
Tsai, M.-C., Manor, O., Wan, Y., Mosammaparast, N., Wang, J. K., Lan, F., Shi, Y., Segal, E., & Chang, H. Y. (2010) · Science · doi:10.1126/science.1192002 · Cited by 3,290 · cited 1×
“Among the best studied examples is the long ncRNA HOTAIR, which is transcribed from the HOXC cluster and was shown to repress genes in the HOXD cluster in trans [25,26].”
Background
Cited by
Items 101–200 of 403
Zhang, X., Xue, C., Lin, J. J., Ferguson, J. F., Weiner, A. K., Liu, W., Han, Y., Hinkle, C. C., Li, W., Jiang, H., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aar5987 · Cited by 59
“3 locus has been implicated in coronary heart disease (41, 53), linc-NFE2L-3 has been implicated in central obesity (54), and CCAT2 at 8q24.”
BackgroundMolecular function and regulation of long non-coding RNAs: paradigms with potential roles in cancer
Hajjari, M., Khoshnevisan, A., & Shin, Y. K. (2014) · Tumor Biology · doi:10.1007/s13277-014-2636-z · Cited by 58
“It seems that the transregulation executed by ANRIL is dependent on Alu motifs in this RNA and promoters of its targets [100].”
BackgroundPosttranscriptional regulation of lipid metabolism by non-coding RNAs and RNA binding proteins
Singh, A. K., Aryal, B., Zhang, X., Fan, Y., Price, N. L., Suárez, Y., & Fernández-Hernando, C. (2018) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2017.11.026 · Cited by 54
Zhao, Q., Wirka, R. C., Nguyen, T., Nagao, M., Cheng, P. P., Miller, C. L., Kim, J. B., Pjanic, M., & Quertermous, T. (2019) · Genome Medicine · doi:10.1186/s13073-019-0635-9 · Cited by 57
Long Noncoding RNAs in Lung Cancer
Roth, A., & Diederichs, S. (2015) · Current topics in microbiology and immunology · doi:10.1007/82_2015_444 · Cited by 53
“A recent study revealed that Alu elements within ANRIL transcripts convey specificity in the genome-wide trans-regulation of genes (Holdt et al. 2013).”
BackgroundTranscriptional profiling analysis and functional prediction of long noncoding RNAs in cancer
Yuan, J., Yue, H., Zhang, M., Luo, J., Liu, L., Wu, W., Xiao, T., Chen, X., Chen, X., Zhang, D., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.6993 · Cited by 57
“However, since lncRNAs have been implicated to play important roles in multiple biological processes such as cell cycle [12], cell apoptosis [13] as well as signal pathway [14, 15], lncRNAs might function as tumor suppressors or oncogenic drivers [16].”
BackgroundRole of Non-Coding RNAs in Stroke
Tiedt, S., & Dichgans, M. (2018) · Stroke · doi:10.1161/strokeaha.118.021010 · Cited by 53
“atheroprogressive effects by trans-regulation of related gene networks.(14) Second, the miR-143/miR-145 cluster promotes”
BackgroundThe Role of ANRIL in Atherosclerosis
Razeghian‐Jahromi, I., Akhormeh, A. K., & Zibaeenezhad, M. J. (2022) · Disease Markers · doi:10.1155/2022/8859677 · Cited by 59
“It means that cell uses circularization as a way to avoid synthesis of linear forms preventing plaque growth (Figure 2) [47, 80, 81].”
BackgroundSarkar, D., Oghabian, A., Bodiyabadu, P. K., Joseph, W. R., Leung, E. Y., Finlay, G. J., Baguley, B. C., & Askarian-Amiri, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071378 · Cited by 58
Sweta, S., Dudnakova, T., Sudheer, S., Baker, A. H., & Bhushan, R. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00228 · Cited by 64
“Further investigations revealed that ANRIL functions in trans, leading to pro-atherogenic effects such as cell proliferation, increased cell adhesion and decreased apoptosis (Holdt et al., 2013).”
BackgroundLEADeR role of miR-205 host gene as long noncoding RNA in prostate basal cell differentiation
Profumo, V., Forte, B., Percio, S., Rotundo, F., Doldi, V., Ferrari, E., Fenderico, N., Dugo, M., Romagnoli, D., Benelli, M., et al. (2019) · Nature Communications · doi:10.1038/s41467-018-08153-2 · Cited by 61
Genome-wide association studies of late-onset cardiovascular disease
Smith, J. G., & Newton‐Cheh, C. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.04.004 · Cited by 56
“Taken together, these results implicate CDKN2A/CDKN2B/CDKN2BAS1 as a novel link between inflammatory signaling and vascular proliferation.”
BackgroundGenetics of Ischemic Stroke in Young Adults
Cheng, Y., Cole, J. W., Kittner, S. J., & Mitchell, B. D. (2014) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.113.000390 · Cited by 48
Epigenetics and vascular diseases
Stratton, M. S., Farina, F. M., & Elia, L. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.06.010 · Cited by 51
Nakaoka, H., Gurumurthy, A., Hayano, T., Ahmadloo, S., Omer, W. H., Yoshihara, K., Yamamoto, A., Kurose, K., Enomoto, T., Akira, S., et al. (2016) · PLOS Genetics · doi:10.1371/journal.pgen.1005893 · Cited by 46
Burkhardt, R., Kirsten, H., Beutner, F., Holdt, L. M., Gross, A., Teren, A., Tönjes, A., Becker, S., Krohn, K., Kovacs, P. L., et al. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005510 · Cited by 48
Self-citationRoyds, J. A., Pilbrow, A. P., Ahn, A., Morrin, H. R., Frampton, C. M., Russell, I. A., Moravec, C. S., Sweet, W. E., Tang, W. H. W., Currie, M. J., et al. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2015.00306 · Cited by 46
Rankin, C. R., Lokhandwala, Z. A., Huang, R., Pekow, J. R., Pothoulakis, C., & Padua, D. M. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116571 · Cited by 48
“CDKN2B-AS1 has also been shown to increase cell proliferation, increase cell adhesion, and decrease apoptosis [24,25].”
BackgroundThe Long Non-Coding RNA ANRIL in Cancers
Sanchez, A., Lhuillier, J., Grosjean, G., Ayadi, L., & Maenner, S. (2023) · Cancers · doi:10.3390/cancers15164160 · Cited by 56
“Interestingly, TEs cover 35% of the ANRIL sequence, and the Exon8, which is 70% covered by the subcategory of LTR named ERVL-MaLR, has been described to be involved in ANRIL genomic occupancy [19,20].”
BackgroundDark matter RNA illuminates the puzzle of genome-wide association studies
Laurent, G. S., Vyatkin, Y. V., & Kapranov, P. (2014) · BMC Medicine · doi:10.1186/1741-7015-12-97 · Cited by 47
Rey, F., Urrata, V., Gilardini, L., Bertoli, S., Calcaterra, V., Zuccotti, G., Cancello, R., & Carelli, S. (2021) · Obesity Reviews · doi:10.1111/obr.13203 · Cited by 46
A Multilayered Control of the Human Survival Motor Neuron Gene Expression by Alu Elements
Ottesen, E. W., Seo, J., Singh, N. N., & Singh, R. N. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02252 · Cited by 43
“For instance, ANRIL, a lncRNA identified in a GWAS as a risk factor in coronary artery disease, has been suggested to regulate expression of a network of genes through Alu elements located in their promoters (Holdt et al., 2013).”
BackgroundInfluentialHubberten, M., Bochenek, G., Chen, H., Häsler, R., Wiehe, R., Rosenstiel, P. C., Jepsen, S. V., Dommisch, H., & Schäefer, A. S. (2018) · European Journal of Human Genetics · doi:10.1038/s41431-018-0210-7 · Cited by 45
Circulating “LncPPARδ” From Monocytes as a Novel Biomarker for Coronary Artery Diseases
Cai, Y., Yang, Y., Chen, X., He, D., Zhang, X., Wen, X., Hu, J., Fu, C., Qiu, D., José, P. A., et al. (2016) · Medicine · doi:10.1097/md.0000000000002360 · Cited by 43
Long noncoding RNA variations in cardiometabolic diseases
Dechamethakun, S., & Muramatsu, M. (2016) · Journal of Human Genetics · doi:10.1038/jhg.2016.70 · Cited by 45
Podbevšek, P., Fasolo, F., Bon, C., Cimatti, L., Reißer, S., Carninci, P., Bussi, G., Zucchelli, S., Plavec, J., & Gustincich, S. (2018) · Scientific Reports · doi:10.1038/s41598-017-14908-6 · Cited by 42
Expedition to the missing link: Long noncoding RNAs in cardiovascular diseases
Yeh, C., Chang, Y.-C. E., Lu, C.-Y., Hsuan, C., Chang, W., & Yang, K. (2020) · Journal of Biomedical Science · doi:10.1186/s12929-020-00647-w · Cited by 45
Kumar, A., Thomas, S., Wong, K. C., Sardo, V. L., Cheah, D. S., Hou, Y., Placone, J. K., Tenerelli, K. P., Ferguson, W. C., Torkamani, A., et al. (2019) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0344-5 · Cited by 44
Long Noncoding RNAs in Atherosclerosis
Jian, L., Jian, D., Chen, Q., & Zhang, L. (2015) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.33167 · Cited by 41
Zhang, X., Li, D. Y., & Reilly, M. P. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.09.040 · Cited by 41
Gandhi, M., Caudron‐Herger, M., & Diederichs, S. (2018) · Nature Structural & Molecular Biology · doi:10.1038/s41594-018-0155-0 · Cited by 45
Multi-Omics Approaches to Study Long Non-coding RNA Function in Atherosclerosis
Turner, A. W., Wong, D., Khan, M. D., Dreisbach, C., Palmore, M., & Miller, C. L. (2019) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2019.00009 · Cited by 40
“Dozens of lncRNAs with no previous evidence for roles in VSMC differentiation were identified in this analysis that warrant further investigation, either as cis transcriptional regulators or suppressing miRNA function (130).”
BackgroundInfluentialLncRNA ANRIL mediates endothelial dysfunction through BDNF downregulation in chronic kidney disease
Su, H., Liu, B., Chen, H., Zhang, T., Huang, T., Liu, Y., Wang, C., Ma, Q., Wang, Q., Lv, Z., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05068-1 · Cited by 41
“6C, Δ1: [381-752]; Δ2: [1-380] + [501-752]; Δ3: [1500]) were constructed from Ribobio Biosciences, cell transfection was performed with the Lipofectamine 3000 Transfection Reagent following the handbook of transfection reagent.”
BackgroundMethodEpigenetic modulation in the treatment of atherosclerotic disease
Byrne, M. M., Murphy, R. T., & Ryan, A. W. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00364 · Cited by 40
Wang, Z., Schwacke, R., & Kunze, R. (2016) · Molecular Plant · doi:10.1016/j.molp.2016.04.015 · Cited by 39
“, TUG1, ANRIL, and lncRNA-JADE, contain TE sequences (Kelley and Rinn, 2012; He et al., 2013; Holdt et al., 2013; Wan et al., 2013a, 2013b), and it was suggested that these TEs act as RNA-, DNA-, or protein-binding domains and provide essential regulatory functions of lncRNAs (Johnson and Guigo, 2014).”
BackgroundEndothelial miRNAs as Cellular Messengers in Cardiometabolic Diseases
Njock, M., & Fish, J. E. (2016) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2016.11.009 · Cited by 40
Expression status and clinical significance of lncRNA APPAT in the progression of atherosclerosis
Meng, F., Yan, J., Ma, Q., Jiao, Y., Han, L., Xu, J., Yang, F., & Liu, J. (2018) · PeerJ · doi:10.7717/peerj.4246 · Cited by 39
“290 Discussion 291 Increasing evidences shows that lncRNAs with various classification plays the critical role in 292 atherosclerosis, although they were considered as junk of genome in the past (Holdt et al. 2013; 293 Michalik et al. 2014).”
BackgroundAPOL1, CDKN2A/CDKN2B, and HDAC9 polymorphisms and small vessel ischemic stroke
Akinyemi, R., Tiwari, H. K., Arnett, D. K., Ovbiagele, B. I., Irvin, M. R., Wahab, K., Sarfo, F. S., Srinivasasainagendra, V., Adeoye, A., Perry, R. T., et al. (2017) · Acta Neurologica Scandinavica · doi:10.1111/ane.12847 · Cited by 41
Ballantyne, R. L., Zhang, X., Núñez, S., Xue, C., Zhao, W., Reed, E. R., Salaheen, D., Foulkes, A. S., Li, M., & Reilly, M. P. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw154 · Cited by 37
“We do not propose that our annotated chr9p21 lincRNAs provide an alternative explanation to ANRIL for CAD and MI association—rather, our findings are consistent with studies that have interrogated the locus in greater depth and implicated the ANRIL family of lncRNAs (32,33).”
BackgroundResultGenome-wide meta-analysis identifies novel loci of plaque burden in carotid artery
Pott, J., Burkhardt, R., Beutner, F., Horn, K., Teren, A., Kirsten, H., Holdt, L. M., Schuler, G. C., Teupser, D., Loeffler, M., et al. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.02.018 · Cited by 38
Self-citationThe control of polycomb repressive complexes by long noncoding RNAs
Trotman, J. B., Braceros, K. C. A., Cherney, R. E., Murvin, M. M., & Calabrese, J. M. (2021) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1657 · Cited by 53
“A detailed discussion of each lncRNA is beyond the scope of this review (Amandio et al., 2016; d'Ydewalle et al., 2017; Gupta et al., 2010; Holdt et al., 2013; Huarte et al., 2010; Jia et al., 2016; Jin et al., 2018; Kang et al., 2020; Klattenhoff et al., 2013; Kotake et al., 2011; Kotzin et al.,…”
BackgroundThe role of long non-coding RNA ANRIL in the development of atherosclerosis
Фанилевич, Г. И., Kudriashov, V., Sufianov, A. A., Begliarzade, S., Ilyasova, T., Liang, Y., & Beylerli, O. (2022) · Non-coding RNA Research · doi:10.1016/j.ncrna.2022.09.002 · Cited by 41
Identification and regulation of the long non-coding RNA Heat2 in heart failure
Boeckel, J., Perret, M. F., Glaser, S.-F., Seeger, T., Heumüller, A. W., Chen, W., John, D., Kokot, K. E., Katus, H. A., Haas, J., et al. (2018) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2018.11.004 · Cited by 36
Das, M., Renganathan, A., Dighe, S. N., Bhaduri, U., Shettar, A., Mukherjee, G., Kondaiah, P., & Rao, M. R. S. (2017) · RNA Biology · doi:10.1080/15476286.2017.1397261 · Cited by 35
Unveiling ncRNA regulatory axes in atherosclerosis progression
Navarro, E., Mallén, A., Cruzado, J. M., Torrás, J., & Hueso, M. (2020) · Clinical and Translational Medicine · doi:10.1186/s40169-020-0256-3 · Cited by 37
Pathological Bases and Clinical Application of Long Noncoding RNAs in Cardiovascular Diseases
Zhang, C., Niu, K., Lian, P., Hu, Y., Shuai, Z., Gao, S., Ge, S., Xu, T., Xiao, Q., & Chen, Z. (2021) · Hypertension · doi:10.1161/hypertensionaha.120.16752 · Cited by 36
Noncoding RNAs in Polycomb and Trithorax Regulation: A Quantitative Perspective
Ringrose, L. (2017) · Annual Review of Genetics · doi:10.1146/annurev-genet-120116-023402 · Cited by 34
Genetic Insights Into Smooth Muscle Cell Contributions to Coronary Artery Disease
Wong, D., Turner, A. W., & Miller, C. L. (2019) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.119.312141 · Cited by 40
“functions through Alu element–mediated transregulatory networks.(46,47) However, circular ANRIL inhibits atherogenic pro-”
BackgroundThe Role of Long Non-Coding RNAs in Endometriosis
Hudson, Q. J., Proestling, K., Perricos, A., Kuessel, L., Husslein, H., Wenzl, R. J., & Yotova, I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111425 · Cited by 36
Long noncoding RNAs in gastric cancer carcinogenesis and metastasis
Nasrollahzadeh-Khakiani, M., Emadi‐Baygi, M., Schulz, W. A., & Nikpour, P. (2016) · Briefings in Functional Genomics · doi:10.1093/bfgp/elw011 · Cited by 36
Carotid Artery Atherosclerosis: A Review on Heritability and Genetics
Forgó, B., Medda, E., Hernyes, A., Szalontai, L., Tárnoki, D. L., & Tárnoki, Á. D. (2018) · Twin Research and Human Genetics · doi:10.1017/thg.2018.45 · Cited by 37
“TheCDKN2A/B gene is located at the 9p21 locus, which is subject of intensive research and the relevance of which in atherosclerosis is undoubted (Holdt & Teupser, 2012; Holdt et al., 2010, 2011, 2013, 2016).”
BackgroundSun, L., Tu, J., Liu, C., Pan, A., Xia, X., & Chen, X. (2019) · Inflammopharmacology · doi:10.1007/s10787-019-00666-6 · Cited by 37
Long Non-Coding RNAs Embedded in the Rb and p53 Pathways
Subramanian, M., Jones, M. F., & Lal, A. (2013) · Cancers · doi:10.3390/cancers5041655 · Cited by 38
STAT3-induced long noncoding RNAs in multiple myeloma cells display different properties in cancer
Binder, S., Hösler, N., Riedel, D., Zipfel, I., Buschmann, T., Kämpf, C., Reiche, K., Burger, R., Gramatzki, M., Hackermüller, J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-08348-5 · Cited by 34
Self-citationUnraveling the DNA methylome of atherosclerosis
Zaina, S. (2014) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000059 · Cited by 35
Endometriosis and risk of cardiovascular disease: a systematic review and meta-analysis
Parsa, S., Noroozpoor, R., Dehghanbanadaki, H., Khateri, S., & Moradi, Y. (2025) · BMC Public Health · doi:10.1186/s12889-025-21486-0 · Cited by 39
Non-Coding RNAs and Lipid Metabolism
Smolle, E., & Haybaeck, J. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms150813494 · Cited by 32
Exploring the read-write genome: mobile DNA and mammalian adaptation
Shapiro, J. A. (2017) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2016.1226748 · Cited by 30
“, 2014) Atherogenesis (Holdt et al., 2013; Li et al., 2016; Lu et al., 2016) Lung development (Herriges et al.”
BackgroundThe function of long non-coding RNAs in vascular biology and disease
Kok, F. O., & Baker, A. H. (2019) · Vascular Pharmacology · doi:10.1016/j.vph.2018.06.004 · Cited by 30
Noncoding RNAs in the Vascular System Response to Oxidative Stress
Fuschi, P., Maimone, B., Gaetano, C., & Martelli, F. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7229 · Cited by 32
“Target selection is mediated, at least in part, by the pairing of repetitive Alu elements in CDKN2B-AS1/ANRIL and its target genes (63).”
The RNA‐binding protein ILF3 binds to transposable element sequences in SINEUP lncRNAs
Fasolo, F., Patrucco, L., Volpe, M., Bon, C., Peano, C., Mignone, F., Carninci, P., Persichetti, F., Santoro, C., Zucchelli, S., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201901618rr · Cited by 35
“An embedded Arthrobacter luteus (Alu) repeat modulates activity of AS noncoding RNA in the INK4 locus by recruiting protein components of the polycomb repressive complex (20).”
BackgroundCohort Profile: The Leipzig Research Center for Civilization Diseases–Heart Study (LIFE-Heart)
Scholz, M. R., Henger, S., Beutner, F., Teren, A., Baber, R., Willenberg, A., Ceglarek, U., Pott, J., Burkhardt, R., & Thiery, J. (2020) · International Journal of Epidemiology · doi:10.1093/ije/dyaa075 · Cited by 30
Self-citationLong non-coding RNAs regulating macrophage functions in homeostasis and disease
Scacalossi, K. R., Solingen, C. V., & Moore, K. J. (2018) · Vascular Pharmacology · doi:10.1016/j.vph.2018.02.011 · Cited by 31
Long Noncoding RNAs as Diagnostic and Therapeutic Targets for Ischemic Stroke
Wang, Q., Liu, X., & Zhu, R. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190328112844 · Cited by 29
The epitranscriptome of long noncoding RNAs in metabolic diseases
Yin, L., Zhu, X., Novák, P., Zhou, L., Gao, L., Yang, M., Zhao, G., & Yin, K. (2021) · Clinica Chimica Acta · doi:10.1016/j.cca.2021.01.001 · Cited by 29
Naemura, M., Tsunoda, T., Inoue, Y., Okamoto, H., Shirasawa, S., & Kotake, Y. (2015) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-015-2618-5 · Cited by 29
Retrotransposon-associated long non-coding RNAs in mice and men
Ganesh, S., & Svoboda, P. (2016) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-016-1818-5 · Cited by 33
“The Alu motif mutations in ANRIL reverse trans-effects and proatherogenic cellular properties [39].”
BackgroundLong Noncoding RNA ANRIL as a Novel Biomarker in Human Cancer
Lou, N., Liu, G., & Pan, Y. (2020) · Future Oncology · doi:10.2217/fon-2020-0470 · Cited by 33
Hueso, M., Cruzado, J. M., Torrás, J., & Navarro, E. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061734 · Cited by 30
“Much interestingly, ANRIL over-expression caused the upregulation of other mRNA transcripts related to cell adhesion, growth and proliferation, an effect that could be reversed by down-regulating ANRIL with a specific siRNA [56].”
BackgroundInfluentialRBPs Play Important Roles in Vascular Endothelial Dysfunction Under Diabetic Conditions
Yang, C., Kelaini, S., Caines, R., & Margariti, A. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01310 · Cited by 29
The role of non-coding RNA network in atherosclerosis
Yuan, Y., Xu, L., Geng, Z., Liu, J., Zhang, L., Wu, Y., He, D., & Qu, P. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118756 · Cited by 27
RETRACTED: lncRNA TRMP-S directs dual mechanisms to regulate p27-mediated cellular senescence
Tian, S., Khan, M. R., Zhang, X. D., Li, J., Thorne, R. F., Wu, M., & Shao, F. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.04.004 · Cited by 30
“lncRNA genes also commonly produce alternative splicing variants, and it has been predicted that lncRNA isoforms could perform drastically different biological functions.(24,25) However, % 1% of lncRNAs have been mechanistically characterized,(26) and even fewer reports have deliberately sought to characterize their a…”
BackgroundRetractedScavenger receptors and non-coding RNAs: relevance in atherogenesis
Dai, Y., Condorelli, G., & Mehta, J. L. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv236 · Cited by 28
In Search for Genes Related to Atherosclerosis and Dyslipidemia Using Animal Models
Poznyak, A. V., Grechko, A. V., Wetzker, R., & Orekhov, A. N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062097 · Cited by 29
“It was shown that ANRIL could promote proliferation of human vascular smooth muscle cells through recruiting repressive PcG protein complexes to the cell cycle inhibitor genes CDKN2A/B [65].”
BackgroundJiang, X., Zhang, F., & Ning, Q. (2015) · Pathologie Biologie · doi:10.1016/j.patbio.2015.04.001 · Cited by 26
Li, Y., Wang, H., & Zhang, Y.-Y. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16849 · Cited by 27
Endothelial long non-coding RNAs regulated by oxidized LDL
Singh, K. K., Matkar, P. N., Pan, Y., Quan, A., Gupta, V., Teoh, H., Al-Omran, M. A., & Verma, S. (2017) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-017-2984-2 · Cited by 28
“The endothelial-expressed lncRNAs MALAT1 and Tie1-AS have been reported to control endothelial function in the vascular system [20, 21], and ANRIL has been demonstrated to regulate cell proliferation, cell adhesion, and apoptosis—cellular activities crucial for atherosclerosis [22].”
BackgroundLin, J. J., & Musunuru, K. (2018) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.117.001946 · Cited by 29
Hu, D., Li, Z., Zhu, Y.-T., & Li, C. (2020) · Aging · doi:10.18632/aging.202392 · Cited by 27
Kattan, S. W., Hobani, Y. H., Shaheen, S. Y., Mokhtar, S. H., Hussein, M. H., Toraih, E. A., Fawzy, M. S., & Abdalla, H. A. (2021) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-021-00258-9 · Cited by 27
The cis and trans effects of the risk variants of coronary artery disease in the Chr9p21 region
Zhao, W., Smith, J. A., Mao, G., Fornage, M., Peyser, P. A., Sun, Y. V., Turner, S. T., & Kardia, S. L. R. (2015) · BMC Medical Genomics · doi:10.1186/s12920-015-0094-0 · Cited by 25
“Other evidence suggests that ANRIL may also affect various genes by trans effect [44-46].”
Villegas, V. E., Rahman, M. F., Fernández‐Barrena, M. G., Diao, Y., Liapi, E., Sonkoly, E., Ståhle, M., Pivarcsi, A., Annaratone, L., Sapino, A., et al. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.03.009 · Cited by 25
LET's sponge: How the lncRNA PFL promotes cardiac fibrosis
Leisegang, M. S. (2017) · Theranostics · doi:10.7150/thno.23364 · Cited by 26
“Among others, MANTIS and ANRIL (antisense noncoding RNA in the INK4 locus) are examples of lncRNAs containing such transposable elements.”
BackgroundThe Long Non-Coding RNA Landscape of Atherosclerotic Plaques
Kraczkowska, W., & Jagodziński, P. P. (2019) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-019-00427-9 · Cited by 25
Fasolo, F., Paloschi, V., & Mäegdefessel, L. (2022) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2022.11.021 · Cited by 25
Wang, C., & Huang, S. (2014) · Nucleus · doi:10.4161/nucl.28005 · Cited by 25
Aarabi, G., Zeller, T., Heydecke, G., Munz, M., Schäfer, A. S., & Seedorf, U. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00047 · Cited by 32
Zhai, H., Li, X., Liu, F., Chen, B., Zheng, H., Wang, X., Liao, W., Chen, Q., Ma, Y., & Yang, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.16355 · Cited by 23
LncRNA secondary structure in the cardiovascular system
Martens, L., Rühle, F., & Stoll, M. (2017) · Non-coding RNA Research · doi:10.1016/j.ncrna.2017.12.001 · Cited by 23
Cardiovascular inflammation: RNA takes the lead
Martens, C. R., Bansal, S. S., & Accornero, F. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.03.012 · Cited by 24
“ANRIL has been found to interact with a pro-inflammatory transcription factor called Yin Yang 1 (YY1), which is known to be a downstream modulator of NF-κB signaling [83,86].”
BackgroundVerjans, R., van Bilsen, M., & Schroen, B. L. M. (2020) · Biomolecules · doi:10.3390/biom10020262 · Cited by 24
Zhang, S., Li, Y., Xin, S., Yang, L., Jiang, M., Xin, Y., Wang, Y., Yang, J., & Lu, J. (2022) · Cancers · doi:10.3390/cancers14194564 · Cited by 27
Gao, F., Yu, L., Zhang, D., Zhang, Y., Wang, R., & Zhao, J. (2016) · World Neurosurgery · doi:10.1016/j.wneu.2016.05.081 · Cited by 23
Yari, M., Bitarafan, S., Broumand, M. A., Fazeli, Z., Rahimi, M., Ghaderian, S. M. H., Mirfakhraie, R., & Omrani, M. D. (2018) · PubMed Central · doi:10.22088/ijmcm.bums.7.1.1 · Cited by 24
“Furthermore, the expression of ANRIL variants have been shown to be different between patients affected by atherosclerosis and healthy individuals (17).”
BackgroundThe role of Alu-derived RNAs in Alzheimer’s and other neurodegenerative conditions
Polesskaya, O., Kananykhina, E. Y., Roy‐Engel, A. M., Nazarenko, O., Kulemzina, I. A., Baranova, A. V., Vassetzky, Y. S., & Myakishev-Rempel, M. (2018) · Medical Hypotheses · doi:10.1016/j.mehy.2018.03.008 · Cited by 23
Circular RNAs: novel diagnostic and therapeutic targets for ischemic stroke
Wang, Q., Liu, X., Zhao, J., & Zhu, R. (2020) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2020.1826313 · Cited by 23
Regulatory Roles of Related Long Non-coding RNAs in the Process of Atherosclerosis
Meng, Q., Pu, L., Luo, X., Wang, B., Li, F., & Liu, B. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.564604 · Cited by 23
The emerging landscape of non-conventional RNA functions in atherosclerosis
Farina, F. M., Weber, C., & Santovito, D. (2023) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2023.01.009 · Cited by 23
Hoffmann, M. J., Dehn, J., Droop, J., Niegisch, G., Niedworok, C., Szarvas, T., & Schulz, W. A. (2015) · Non-Coding RNA · doi:10.3390/ncrna1030266 · Cited by 23
Huang, Q., Pan, M., Zhou, J., & Yin, F. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15343 · Cited by 22
Metadata
- Authors
- Holdt, L. M., Hoffmann, S., Sass, K., Langenberger, D., Scholz, M., Krohn, K., Finstermeier, K., Stahringer, A., Wilfert, W., Beutner, F., Gielen, S., Schuler, G., Gäbel, G., Bergert, H., Bechmann, I., Stadler, P. F., Thiery, J., & Teupser, D.
- Affiliations
- University Hospital Leipzig (DE)
- Leipzig University (DE)
- Technische Universität Dresden (DE)
- Santa Fe Institute (US)
- Corresponding author
- Teupser, Daniel
- ORCID
- Venue
- PLoS Genetics
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-07-04
- Volume
- 9
- Issue
- 7
- Pages
- e1003588
- ISSN
- 1553-7390 (ISSN-L)
- 1553-7404
- PMC
- PMC3701717
- OpenAlex
- W1972104572
- Cited by
- 397
- References
- 62
- Citations by year
- 2026: 14 · 2025: 13 · 2024: 12 · 2023: 18 · 2022: 36 · 2021: 33 · 2020: 42 · 2019: 38 · 2018: 40 · 2017: 43 · 2016: 37 · 2015: 41 · 2014: 27 · 2013: 3
- FWCI
- 12.65
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Genetics (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Max Planck Institute for Plasma Physics (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- European Commission
- Freistaat Sachsen
- European Regional Development Fund
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- ANRIL, Alu elements, chromosome 9p21, long non-coding RNA, trans-regulation, atherosclerosis, coronary artery disease, Polycomb group proteins, epigenetic regulation, cell proliferation, cell adhesion, apoptosis, risk alleles
- MeSH terms
- Cell Adhesion, Chromosomes, Human, Pair 9, Coronary Artery Disease, Gene Expression Regulation, Humans, Apoptosis, Genetic Predisposition to Disease, Alu Elements, Polymorphism, Single Nucleotide, Epigenesis, Genetic, Cell Proliferation, Atherosclerosis, Gene Regulatory Networks, Genome-Wide Association Study, HEK293 Cells, RNA, Long Noncoding, Polycomb-Group Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.